Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	228.12	222.5	286.33	28	31.34	142.09
Short-Term Investments	76.43	57.81	-	123.72	125.2	89.73
Cash & Short-Term Investments	304.55	280.32	286.33	151.72	156.54	231.82
Cash Growth	9.40%	-2.10%	88.72%	-3.08%	-32.47%	98.71%
Accounts Receivable	106.84	78.29	67.97	23.99	3.27	-
Other Receivables	-	-	-	-	0.3	-
Receivables	106.84	78.29	67.97	23.99	3.57	-
Inventory	22.94	22.4	22.31	5.57	1.51	-
Prepaid Expenses	19.07	11.78	10.94	8.95	4.97	4.53
Total Current Assets	453.4	392.79	387.54	190.23	166.59	236.35
Property, Plant & Equipment	10.12	9.81	1.99	2.35	2.55	3.24
Long-Term Investments	17.11	12.53	-	-	4.98	-
Other Intangible Assets	237.87	249.82	252.93	58.95	18.74	-
Other Long-Term Assets	7.32	5.81	4.17	101.38	101.79	1.27
Total Assets	725.83	670.75	646.62	352.91	294.65	240.86
Accounts Payable	17.66	14.62	7.42	8.69	9.17	3.15
Accrued Expenses	72.18	72.86	54.89	34.73	24.42	13.41
Current Portion of Leases	2.08	1.71	1.1	0.93	0.71	0.64
Other Current Liabilities	52.88	37.36	23.65	20.37	8.3	1.26
Total Current Liabilities	144.8	126.55	87.06	64.73	42.6	18.46
Long-Term Debt	308.93	308.08	306.42	-	-	-
Long-Term Leases	7.88	7.97	0.62	1.26	1.9	2.63
Other Long-Term Liabilities	9.05	2.51	3.85	144.88	129.94	47.68
Total Liabilities	470.67	445.11	397.95	210.87	174.44	68.77
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	919.52	870.19	803.26	535.07	377.4	345.18
Retained Earnings	-664.72	-644.18	-556.24	-392.82	-257.16	-173.17
Comprehensive Income & Other	0.35	-0.37	1.64	-0.22	-0.04	0.08
Total Common Equity	255.16	225.64	248.67	142.04	120.21	172.1
Shareholders' Equity	255.16	225.64	248.67	142.04	120.21	172.1
Total Liabilities & Equity	725.83	670.75	646.62	352.91	294.65	240.86
Total Debt	318.9	317.76	308.14	2.19	2.61	3.26
Net Cash (Debt)	-14.35	-37.45	-21.82	149.53	153.93	228.56
Net Cash Growth	-	-	-	-2.86%	-32.65%	102.24%
Net Cash Per Share	-0.29	-0.79	-0.53	4.40	5.08	9.05
Filing Date Shares Outstanding	50.24	49.01	47	37.95	31.73	30.42
Total Common Shares Outstanding	50.06	48.34	46.72	36.96	30.58	29.78
Working Capital	308.6	266.24	300.48	125.5	124	217.89
Book Value Per Share	5.10	4.67	5.32	3.84	3.93	5.78
Tangible Book Value	17.29	-24.18	-4.26	83.08	101.47	172.1
Tangible Book Value Per Share	0.35	-0.50	-0.09	2.25	3.32	5.78
Machinery	-	1.64	0.91	0.6	0.2	0.3
Leasehold Improvements	-	0.2	1.3	1.31	1.48	1.29

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q